GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Klaria Pharma Holding AB (OSTO:KLAR) » Definitions » Cyclically Adjusted PB Ratio

Klaria Pharma Holding AB (OSTO:KLAR) Cyclically Adjusted PB Ratio : 0.13 (As of Jun. 03, 2025)


View and export this data going back to 2015. Start your Free Trial

What is Klaria Pharma Holding AB Cyclically Adjusted PB Ratio?

As of today (2025-06-03), Klaria Pharma Holding AB's current share price is kr0.45. Klaria Pharma Holding AB's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2024 was kr3.34. Klaria Pharma Holding AB's Cyclically Adjusted PB Ratio for today is 0.13.

The historical rank and industry rank for Klaria Pharma Holding AB's Cyclically Adjusted PB Ratio or its related term are showing as below:

OSTO:KLAR' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.09   Med: 0.24   Max: 0.51
Current: 0.13

During the past years, Klaria Pharma Holding AB's highest Cyclically Adjusted PB Ratio was 0.51. The lowest was 0.09. And the median was 0.24.

OSTO:KLAR's Cyclically Adjusted PB Ratio is ranked better than
95.09% of 693 companies
in the Drug Manufacturers industry
Industry Median: 1.94 vs OSTO:KLAR: 0.13

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Klaria Pharma Holding AB's adjusted book value per share data for the three months ended in Dec. 2024 was kr0.023. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is kr3.34 for the trailing ten years ended in Dec. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Klaria Pharma Holding AB Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Klaria Pharma Holding AB's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Klaria Pharma Holding AB Cyclically Adjusted PB Ratio Chart

Klaria Pharma Holding AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 0.10

Klaria Pharma Holding AB Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 0.24 0.10

Competitive Comparison of Klaria Pharma Holding AB's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Klaria Pharma Holding AB's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Klaria Pharma Holding AB's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Klaria Pharma Holding AB's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Klaria Pharma Holding AB's Cyclically Adjusted PB Ratio falls into.


;
;

Klaria Pharma Holding AB Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Klaria Pharma Holding AB's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=0.45/3.34
=0.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Klaria Pharma Holding AB's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2024 is calculated as:

For example, Klaria Pharma Holding AB's adjusted Book Value per Share data for the three months ended in Dec. 2024 was:

Adj_Book=Book Value per Share/CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=0.023/132.9872*132.9872
=0.023

Current CPI (Dec. 2024) = 132.9872.

Klaria Pharma Holding AB Quarterly Data

Book Value per Share CPI Adj_Book
201503 0.000 99.950 0.000
201506 0.000 99.995 0.000
201509 5.571 100.228 7.392
201512 5.457 100.276 7.237
201603 5.337 100.751 7.045
201606 5.198 101.019 6.843
201609 5.100 101.138 6.706
201612 5.002 102.022 6.520
201703 4.904 102.022 6.392
201706 4.871 102.752 6.304
201709 4.833 103.279 6.223
201712 3.715 103.793 4.760
201803 4.558 103.962 5.831
201806 4.421 104.875 5.606
201809 4.308 105.679 5.421
201812 2.884 105.912 3.621
201903 2.820 105.886 3.542
201906 2.580 106.742 3.214
201909 2.554 107.214 3.168
201912 2.399 107.766 2.960
202003 2.408 106.563 3.005
202006 2.247 107.498 2.780
202009 2.032 107.635 2.511
202012 1.983 108.296 2.435
202103 1.681 108.360 2.063
202106 1.998 108.928 2.439
202109 1.723 110.338 2.077
202112 1.256 112.486 1.485
202203 1.133 114.825 1.312
202206 0.905 118.384 1.017
202209 0.000 122.296 0.000
202212 0.971 126.365 1.022
202303 0.664 127.042 0.695
202306 0.569 129.407 0.585
202309 0.476 130.224 0.486
202312 0.386 131.912 0.389
202403 0.274 132.205 0.276
202406 0.160 132.716 0.160
202409 0.100 132.304 0.101
202412 0.023 132.987 0.023

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Klaria Pharma Holding AB  (OSTO:KLAR) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Klaria Pharma Holding AB Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Klaria Pharma Holding AB's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Klaria Pharma Holding AB Business Description

Traded in Other Exchanges
Address
Virdings Alle 2, Uppsala, SWE, 754 50
Klaria Pharma Holding AB is engaged in the development and commercialization of pharmaceutical products in Sweden for migraine and cancer-related pain. Its operations are based on a patented drug delivery platform in the form of an alginate-based polymer film. Majority of the group's operations are conducted in Sweden.

Klaria Pharma Holding AB Headlines

From GuruFocus

Klarna (KLAR) Delays IPO Amid Market Volatility

By GuruFocus News 04-04-2025